XML 94 R80.htm IDEA: XBRL DOCUMENT v3.24.0.1
Segment Information (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
USD ($)
segment
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Segment Reporting Information [Line Items]      
Number Of Products And Services 12,000    
Net sales $ 2,671,300 $ 2,802,200 $ 2,922,500
Interest expense 49,439 38,114 1,551
Depreciation and amortization 145,900 137,300 137,600
Segment profit 337,796 482,616 500,336
Total assets $ 12,299,070 13,501,666  
Number of Reportable Segments | segment 2    
Operating Segments [Member]      
Segment Reporting Information [Line Items]      
Segment profit $ 337,800 482,600 500,300
Total assets 780,500 719,300  
Life Science [Member]      
Segment Reporting Information [Line Items]      
Net sales 1,178,400 1,347,200 1,400,800
Depreciation and amortization 62,800 57,900 54,800
Segment profit 108,900 266,800 319,700
Life Science [Member] | Operating Segments [Member]      
Segment Reporting Information [Line Items]      
Total assets 287,100 269,900 207,700
Clinical Diagnostics [Member]      
Segment Reporting Information [Line Items]      
Net sales 1,489,300 1,451,000 1,515,900
Depreciation and amortization 83,100 79,400 82,800
Segment profit 229,600 217,700 181,800
Clinical Diagnostics [Member] | Operating Segments [Member]      
Segment Reporting Information [Line Items]      
Total assets 493,100 448,800 363,500
All Other Segments [Member]      
Segment Reporting Information [Line Items]      
Net sales 3,600 4,000 5,800
Depreciation and amortization 0 0 0
Segment profit (700) (1,900) (1,200)
All Other Segments [Member] | Operating Segments [Member]      
Segment Reporting Information [Line Items]      
Total assets $ 300 $ 600 $ 1,000